NasdaqGS - Nasdaq Real Time Price USD

Clover Health Investments, Corp. (CLOV)

Compare
3.2900 +0.1600 (+5.11%)
At close: January 3 at 4:00:02 PM EST
3.3000 +0.01 (+0.30%)
Pre-Market: 4:01:25 AM EST
Loading Chart for CLOV
DELL
  • Previous Close 3.1300
  • Open 3.1500
  • Bid 3.2400 x 1500
  • Ask 3.3300 x 800
  • Day's Range 3.1450 - 3.3500
  • 52 Week Range 0.6060 - 4.7100
  • Volume 5,472,241
  • Avg. Volume 6,257,077
  • Market Cap (intraday) 1.649B
  • Beta (5Y Monthly) 2.04
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1900
  • Earnings Date Mar 10, 2025 - Mar 14, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 4.68

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.

www.cloverhealth.com/en/

552

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CLOV

View More

Performance Overview: CLOV

Trailing total returns as of 1/3/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

CLOV
3.13%
S&P 500
0.60%

1-Year Return

CLOV
242.71%
S&P 500
25.29%

3-Year Return

CLOV
11.56%
S&P 500
24.68%

5-Year Return

CLOV
67.33%
S&P 500
82.40%

Compare To: CLOV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CLOV

View More

Valuation Measures

As of 1/3/2025
  • Market Cap

    1.65B

  • Enterprise Value

    1.32B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.76

  • Price/Book (mrq)

    4.82

  • Enterprise Value/Revenue

    0.62

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.32%

  • Return on Assets (ttm)

    -5.66%

  • Return on Equity (ttm)

    -28.90%

  • Revenue (ttm)

    2.12B

  • Net Income Avi to Common (ttm)

    -95.94M

  • Diluted EPS (ttm)

    -0.1900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    333.05M

  • Total Debt/Equity (mrq)

    1.07%

  • Levered Free Cash Flow (ttm)

    103.22M

Research Analysis: CLOV

View More

People Also Watch